These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 21130975

  • 21. Efficacy of spironolactone therapy in patients with true resistant hypertension.
    de Souza F, Muxfeldt E, Fiszman R, Salles G.
    Hypertension; 2010 Jan; 55(1):147-52. PubMed ID: 19858405
    [Abstract] [Full Text] [Related]

  • 22. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB, Rao K, Sawyer R, Gottlieb SS.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):845-9. PubMed ID: 16139135
    [Abstract] [Full Text] [Related]

  • 23. Antihypertensive effect and serum potassium homeostasis: comparison of hydrochlorothiazide and spironolactone alone and in combination.
    Nash DT.
    J Med; 1977 Sep 06; 8(5):367-77. PubMed ID: 338851
    [Abstract] [Full Text] [Related]

  • 24. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I, Yalcin S, Ozhan H.
    Kardiol Pol; 2010 Sep 06; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [Abstract] [Full Text] [Related]

  • 25. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Clin Ther; 2007 Feb 06; 29(2):305-15. PubMed ID: 17472822
    [Abstract] [Full Text] [Related]

  • 26. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 06; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 27. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan 06; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 28. Resistant hypertension in a tertiary care clinic.
    Yakovlevitch M, Black HR.
    Arch Intern Med; 1991 Sep 06; 151(9):1786-92. PubMed ID: 1888244
    [Abstract] [Full Text] [Related]

  • 29. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
    Kobalava ZD, Kotovskaya YV, Villevalde SV, Moiseev VS, ARGUS-2 Study.
    Curr Med Res Opin; 2009 Sep 06; 25(9):2229-37. PubMed ID: 19622008
    [Abstract] [Full Text] [Related]

  • 30. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V, Hainer JW, Sugg J, Munzer D, ATTACH Study Group.
    Am J Hypertens; 2006 Dec 06; 19(12):1217-25. PubMed ID: 17161766
    [Abstract] [Full Text] [Related]

  • 31. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr 06; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 32. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients.
    Matsumoto Y, Kageyama S, Yakushigawa T, Arihara K, Sugiyama T, Mori Y, Sugiyama H, Ohmura H, Shio N.
    Cardiology; 2009 Apr 06; 114(1):32-8. PubMed ID: 19342857
    [Abstract] [Full Text] [Related]

  • 33. Factors predicting hyperkalemia in patients with cirrhosis receiving spironolactone.
    Abbas Z, Mumtaz K, Salam A, Jafri W.
    J Coll Physicians Surg Pak; 2003 Jul 06; 13(7):382-4. PubMed ID: 12887837
    [Abstract] [Full Text] [Related]

  • 34. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
    van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F.
    J Hypertens; 2006 Nov 06; 24(11):2285-92. PubMed ID: 17053552
    [Abstract] [Full Text] [Related]

  • 35. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 06; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 36. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994 Mar 06; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 37. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
    Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH.
    Menopause; 2007 Mar 06; 14(3 Pt 1):408-14. PubMed ID: 17224857
    [Abstract] [Full Text] [Related]

  • 38. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto K.
    Pharmacotherapy; 2009 Sep 06; 29(9):1061-72. PubMed ID: 19698011
    [Abstract] [Full Text] [Related]

  • 39. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep 06; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 40. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M, Bellone JM, Wright BM, Rutecki GW.
    Postgrad Med; 2012 Jan 06; 124(1):74-82. PubMed ID: 22314117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.